Da Volterra's DAV132 meets in Phase I for antibiotic-induced dysbiosis

Da Volterra (Paris, France) reported data from the open-label, French Phase I DAV132-CL-1002 trial in 44 healthy volunteers showing

Read the full 197 word article

User Sign In